The sequelae of tuberculosis are still the commonest causes of haemoptysis in the developing
world, where life-threatening haemoptysis remains a common and not infrequently fatal medical
emergency. Haemoptysis can be life-threatening either as a result of compromised gas exchange
or because of circulatory collapse secondary to acute blood loss. Haemodynamic and
ventilatory support, followed by bronchial artery embolisation (BAE) as a bridge to
potentially curative treatment such as lung resection, remains the standard of care. Often
patients do not qualify for surgical intervention and BAE is, at best, a temporary solution.
External beam radiotherapy (EBRT) may be an alternative, curative intervention in the
management of haemoptysis in patients with no alternative options. There is a paucity of
studies reporting the use of EBRT in patients without malignancy and with regards to specific
doses of EBRT. This pilot study aims to explore the potential of varying doses of EBRT in the
management of massive haemoptysis.